{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-007338","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2025-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.897279+00:00","generated_at":"2026-05-17T05:14:59.195618+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sunshine Biopharma dismisses Bush & Associates, appoints M&K CPAS as auditor effective Sept 24, 2025","bullets":["Dismissed Bush & Associates CPA LLC as independent auditor on Sept 24, 2025; no prior disagreements or reportable events.","Retained M&K CPAS, PLLC as new independent registered public accounting firm effective same date.","Audit reports for fiscal years 2023 and 2024 were unqualified; no adverse opinions or modifications.","Company requested Bush & Associates to provide letter agreeing with disclosures; letter not yet received, will be filed by amendment.","Change approved by board and audit committee; no consultations with M&K prior to engagement."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-007338","json":"https://secwatch.observer/filing/0001683168-25-007338.json","markdown":"https://secwatch.observer/filing/0001683168-25-007338.md","text":"https://secwatch.observer/filing/0001683168-25-007338.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825007338/0001683168-25-007338-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825007338/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:14:59.195618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4abb82b6fefb231326695b1f2d8c9eede0583603","claim":"Sunshine Biopharma Inc. engaged M&K CPAS, PLLC as its auditor.","evidence_excerpt":"ublic accounting firm and retained M&K CPAS, PLLC (“M&K”) as its independent auditor. The decision to dismiss Bush & Associates and retain M&K was approved by the unanimous consent of the Company’s board of directors and the Company’s","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825007338/0001683168-25-007338-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"M&K CPAS, PLLC"}],"fact_type":"auditor_change"},{"claim_id":"ae32be9197b449faf3c40f986c5cabdb54631add","claim":"Sunshine Biopharma Inc. dismissed Bush & Associates CPA LLC as its auditor.","evidence_excerpt":"Effective September 24, 2025, Sunshine Biopharma Inc. (the “Company”), dismissed Bush & Associates CPA LLC (“Bush & Associates”), as its independent registered public accounting firm and retained M&K CPAS, PLLC (“M&K”) as its independent auditor.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402328/000168316825007338/0001683168-25-007338-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Bush & Associates CPA LLC"},{"label":"Successor","value":"M&K CPAS, PLLC"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}